Vibativ

telavancin · Theravance Biopharma

Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for Vibativ, covering 2008-10-24 to 2024-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Telavancin Pediatric PK Study (Ages >12 Months to 17 Years) [Phase 1]